期刊文献+

华蟾素对大鼠胸主动脉的缩血管作用及其机制 被引量:8

Effect of cinobufacini on vascular contractile of rat thoracic aorta
在线阅读 下载PDF
导出
摘要 目的:研究中成药华蟾素对大鼠离体胸主动脉环的作用及其机制。方法:采用大鼠离体胸主动脉灌流模型,观察华蟾素对血管张力的影响。结果:华蟾素(2.5、5.0、7.5、10.0 g/L)浓度依赖性地收缩去内皮的大鼠胸主动脉环,收缩幅度分别为(16.3±3.39)%、(52.5±7.70)%、(60.9±8.84)%、(69.2±11.34)%,显著高于内皮完整的大鼠胸主动脉环收缩幅度[(6.2±2.07)%、(14.7±4.91)%、(17.6±5.86)%、(20.3±6.78)%](P<0.01);在无Ca2+液中,10.0 g/L华蟾素对去内皮主动脉环的收缩幅度[(7.1±0.79)%]显著低于有Ca2+液中的收缩幅度[(78.1±4.32)%](P<0.01);维拉帕米(1-0 7m o l/L,V er)预处理可消除10.0 g/L华蟾素的缩血管作用(P<0.01);一氧化氮合酶抑制剂L-NAM E(1-0 4m o l/L)预处理内皮完整的主动脉环,可增强10.0 g/L华蟾素的缩血管作用(P<0.01)。结论:华蟾素对大鼠离体胸主动脉有收缩作用,其缩血管机制与其促使细胞外Ca2+经电压依赖性钙通道内流进入血管平滑肌细胞有关;同时,华蟾素作用于血管内皮细胞,引起血管舒张因子一氧化氮的释放,部分抵消其缩血管效应。 Objective: To examine the effect of cinobufacini on rat thoracic aorta and its mechanism. Methods: Isolated rat thoracic aorta was perfused and isometric tension was recorded by organ bath technique before and after cinobufacini treatment. Results: Cinobufacini induced contraction of isolated thoracic aorta with or without endothelium in a concentration-dependent manner (at concentration of 2.5, 5.0, 7.5, 10.0 g/L). The vasoconstriction effect of cinobufacini was more potent in endothelium-denuded aorta ring [(16.3±3.39)%, (52.5±7.70)%, (60.9±8.84)%, (69.2±11.34)%] than in endothelium-intact aorta ring [(6.2±2.07)%, (14.7±4.91)%, (17.6±5.86)%, (20.3±6.78)%(P〈0.01)]. Its contractile effect was attenuated in Ca^2+-free solution (about 1/10 of that in buffer with 1.25 mmol/L CaCl2) or by the treatment with verapamil (10^-7 mol/L), an L-type calcium channel antagonist. Cinobufacini induced contraction on the endothelium-intact rat aorta was augmented by pretreatment with L-NAME (10^-4mol/L), a nitric oxide synthase inhibitor. Conclusion: Cinobufacini contracts rat thoracic aorta by opening the voltage-dependent Ca^2+ channel and increasing Ca^2+ influx into vascular smooth muscle. Cinobufacini can also stimulate the release of vascular relaxant factor, nitric oxide, from the endothelium and thus antagonize cinobufacini-induced contraction.
出处 《浙江大学学报(医学版)》 CAS CSCD 2006年第2期178-181,共4页 Journal of Zhejiang University(Medical Sciences)
基金 浙江省教育厅科研基金项目(20040205)
关键词 血管收缩/药物作用 华蟾蜍毒素/投药与剂量 胸主动脉 收缩 一氧化氮 Vasoconstriction/drug eff Cinobufagin/admin Thoracic aorta Contraction Ca^2+ Nitric oxide
  • 相关文献

参考文献4

二级参考文献24

  • 1徐向田,荆培棠,李永华,尹清溪,郭振亚,王春英,陆金山,杨本宏,田庚善.华蟾素治疗慢性乙型肝炎病毒携带者临床研究[J].中国中西医结合杂志,1993,13(8):473-475. 被引量:22
  • 2.中华人民共和国药典,2000年版,一部[S].北京:化学工业出版社,2000.1,316—317.
  • 3宣典发,中西医结合杂志,1985年,2期,126页
  • 4王德昌,药学通报,1980年,15卷,426页
  • 5Fujita S, Puri RK, Yu ZX, Travis WD, Ferrans VJ. An ultrastructural study of in vivo interactions between lymphocytes and endothelial cells in the pathogenesis of the vascular leak syndrome induced by interleukin-2. Cancer 1991;68:2169~2174.
  • 6Rosenberg SA, Lotze MT, Mule JJ. NIH conference. New approaches to the immunotherapy of cancer using interleukin-2. Ann Intern Med 1988;108:853~864.
  • 7Tuttle RS, Boppana DP. Antihypertensive effect of interleukin-2. Hypertension 1990;15:89~94.
  • 8Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109~142.
  • 9Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J 1989;3:2007~2018.
  • 10Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327(6122):524~526.

共引文献108

同被引文献126

引证文献8

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部